CRISPR Taking the Front Seat in Immunotherapy

por Kenderian, Saad S., Badley, Andrew D.
Publicado 2020

Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies

por Siegler, Elizabeth L., Kenderian, Saad S.
Publicado 2020

CART Cell Toxicities: New Insight into Mechanisms and Management

por Zahid, Anas, Siegler, Elizabeth L., Kenderian, Saad S.
Publicado 2020

In Reply — Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019

por Temesgen, Zelalem, Kenderian, Saad S., Badley, Andrew D.
Publicado 2021

In vivo CART cell imaging: Paving the way for success in CART cell therapy

por Sakemura, Reona, Can, Ismail, Siegler, Elizabeth L., Kenderian, Saad S.
Publicado 2021

CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities

por Kankeu Fonkoua, Lionel A., Sirpilla, Olivia, Sakemura, Reona, Siegler, Elizabeth L., Kenderian, Saad S.
Publicado 2022

Chimeric Antigen Receptor T‐Cells: Successful Translation of the First Cell and Gene Therapy From Bench to Bedside

por Rodriguez‐Cartagena, Luis G., Bowles, Bradley S., Kurani, Shaheen S., Windebank, Anthony J., Kenderian, Saad S., Greenberg‐Worisek, Alexandra J.
Publicado 2018

Hemolytic Uremic Syndrome Associated With Escherichia coli O157 Infection in an Allogenic Stem Cell Transplant Recipient

por Vera-Aguilera, Jesus, Duma, Narjust, Gast, Kelly, Alkhateeb, Hassan, Tande, Aaron, Leung, Nelson, Hogan, William J., Kenderian, Saad J.
Publicado 2018

A Graduate-Level Interdisciplinary Curriculum in CAR-T Cell Therapy

por Sterner, Rosalie M., Hedin, Karen E., Hayden, Richard E., Nowakowski, Grzegorz S., Wyles, Saranya P., Greenberg-Worisek, Alexandra J., Terzic, Andre, Kenderian, Saad S.
Publicado 2020

S263: CYTOPENIAS, AGE AND CAR-HEMATOTOX SCORE PREDICT THE DEVELOPMENT OF POST CAR T-CELL THERAPY-RELATED MYELOID NEOPLASMS

por Gurney, Mark, Alkhateeb, Hassan, Shah, Syed, Bansal, Radhika, Hathcock, Matthew, Rosenthal, Allison, Kharfan-Dabaja, Mohamed, Kourelis, Taxiarchis, Patnaik, Mrinal, Chen, Dong, Al-Kali, Aref, Kenderian, Saad, Lin, Yi, Shah, Mithun
Publicado 2023

Upregulation of AXL and β-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance

por Sinha, Sutapa, Secreto, Charla R., Boysen, Justin C., Lesnick, Connie, Wang, Zhiquan, Ding, Wei, Call, Timothy G., Kenderian, Saad J., Parikh, Sameer A., Warner, Steven L., Bearss, David J., Ghosh, Asish K., Kay, Neil E.
Publicado 2021

Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center

por Wang, Yucai, Tschautscher, Marcella A., Rabe, Kari G., Call, Timothy G., Leis, Jose F., Kenderian, Saad S., Kay, Neil E., Muchtar, Eli, Van Dyke, Daniel L., Koehler, Amber B., Schwager, Susan M., Slager, Susan L., Parikh, Sameer A., Ding, Wei
Publicado 2020

Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells

por Ruella, Marco, Barrett, David M, Kenderian, Saad S, Shestova, Olga, Hofmann, Ted J, Scholler, John, Lacey, Simon F, Melenhorst, Jan J, Nazimuddin, Farzana, Perazzelli, Jessica, Christian, David A, Hunter, Christopher A, Porter, David L, June, Carl H, Grupp, Stephan A, Gill, Saar
Publicado 2015

Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index

por Wang, Yucai, Achenbach, Sara J., Rabe, Kari G., Shanafelt, Tait D., Call, Timothy G., Ding, Wei, Kenderian, Saad S., Muchtar, Eli, Leis, Jose F., Koehler, Amber B., Schwager, Susan M., Cerhan, James R., Slager, Susan L., Kay, Neil E., Parikh, Sameer A.
Publicado 2021

Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma

por Acosta-Medina, Aldo A., Johnson, Isla McKerrow, Bansal, Radhika, Hathcock, Matthew, Kenderian, Saad J., Durani, Urshila, Khurana, Arushi, Wang, Yucai, Paludo, Jonas, Villasboas, Jose C., Bennani, N. Nora, Johnston, Patrick B., Ansell, Stephen M., Lin, Yi, Alkhateeb, Hassan B.
Publicado 2023

Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma

por Alkhateeb, Hassan B., Mohty, Razan, Greipp, Patricia, Bansal, Radhika, Hathcock, Matthew, Rosenthal, Allison, Murthy, Hemant, Kharfan-Dabaja, Mohamed, Bisneto Villasboas, Jose C., Bennani, Nora, Ansell, Stephen M., Patnaik, Mrinal M., Litzow, Mark R., He, Rong, Chen, Dong, Al-Kali, Aref, Kenderian, Saad S., Lin, Yi, Shah, Mithun Vinod
Publicado 2022

Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome

por Wang, Yucai, Sinha, Sutapa, Wellik, Linda E., Secreto, Charla R., Rech, Karen L., Call, Timothy G., Parikh, Sameer A., Kenderian, Saad S., Muchtar, Eli, Hayman, Suzanne R., Koehler, Amber B., Van Dyke, Daniel L., Leis, Jose F., Slager, Susan L., Dong, Haidong, Kay, Neil E., He, Rong, Ding, Wei
Publicado 2021

The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL

por Parikh, Sameer A., Rabe, Kari G., Kay, Neil E., Call, Timothy G., Ding, Wei, Leis, Jose F., Kenderian, Saad S., Muchtar, Eli, Wang, Yucai, Koehler, Amber B., Schwager, Susan M., Lesnick, Connie E., Kleinstern, Geffen, Van Dyke, Daniel, Hanson, Curtis A., Braggio, Esteban, Slager, Susan L., Shanafelt, Tait D.
Publicado 2021

P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS

por Hwang, Steven, Wang, Jacqueline, Tian, Zizhong, Qi, Xinyue, Jiang, Yi, Zhang, Shijia, Godby, Richard C., Parikh, Sameer, Ding, Wei, Hampel, Paul, Munoz, Javier, Paludo, Jonas, Kenderian, Saad, Muchtar, Eli, Tsang, Mazie, Hilal, Talal, Leis, Jose, Thanarajasingam, Gita, Inwards, David, Nowakowski, Grzegorz S., Ansell, Stephen, Habermann, Thomas, Witzig, Thomas, Kay, Neil, Zhou, Shouhao, Wang, Yucai
Publicado 2023

GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study

por Temesgen, Zelalem, Assi, Mariam, Shweta, F.N.U., Vergidis, Paschalis, Rizza, Stacey A., Bauer, Philippe R., Pickering, Brian W., Razonable, Raymund R., Libertin, Claudia R., Burger, Charles D., Orenstein, Robert, Vargas, Hugo E., Palraj, Raj, Dababneh, Ala S., Chappell, Gabrielle, Chappell, Dale, Ahmed, Omar, Sakemura, Reona, Durrant, Cameron, Kenderian, Saad S., Badley, Andrew D.
Publicado 2020